• No results found

Stem cell therapy for inflammatory bowel disease Duijvestein, M.

N/A
N/A
Protected

Academic year: 2021

Share "Stem cell therapy for inflammatory bowel disease Duijvestein, M."

Copied!
8
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Stem cell therapy for inflammatory bowel disease

Duijvestein, M.

Citation

Duijvestein, M. (2012, February 9). Stem cell therapy for inflammatory bowel disease. Retrieved from https://hdl.handle.net/1887/18462

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/18462

Note: To cite this publication please use the final published version (if applicable).

(2)

Stem Cell Therapy for Inflammatory Bowel Disease

Marjolijn Duijvestein

(3)

The studies described in this thesis were performed at the Department of Gastroenterology and Hepatology of the Leiden University Medical Center, Leiden, the Netherlands.

Layout: Pepijn Duijvestein Cover photograph: Marjolijn Duijvestein Cover design: Nina Sickenga

ISBN/EAN: 978-90-818537-0-5 Copyright © 2012 M. Duijvestein, Amsterdam, the Netherlands. All rights reserved.

No part of this book may be reproduced or transmitted in any form or by any means, without prior written admission of the author.

Printed by: Haveka, Alblasserdam (www.haveka.nl/greening) This publication (cover and interior) is printed on recycled paper, Revive with ink form renewable resources and alcohol free fountain solution.

Recycled, EU Flower, FSC, ISCO 14001

Financial support for the publication of this thesis was kindly provided by ABBOTT Immunology, Bayer HealthCare Pharmaceuticals, ChipSoft B.V., Dr. Falk Pharma Benelux B.V.

Dutch Digestive Foundation (Maag Lever Darm Stichting), EuroTec B.V., J.E. Jurriaanse Stichting, Ferring B.V.

Merck Sharp & Dohme B.V, Netherlands Society of Gastroenterology (NVGE), Olympus Nederland B.V.

Section Experimental Gastroenterology (SEG) of the Netherlands Society of Gastroenterology (NVGE), Tramedico B.V.

Printed by: Haveka, Alblasserdam (www.haveka.nl/greening). This publication (cover and interior) is printed on recycled paper ‘Revive’ with ink form renewable resources and alcohol free fountain solution. Recycled, EU Flower, FSC, ISCO 14001

(4)

Stem Cell Therapy for Inflammatory Bowel Disease

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof. mr. P. F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 9 februari 2012

klokke 13.45 uur door

Marjolijn Duijvestein

geboren te Tegucigalpa (Honduras) in 1982

(5)

Promotiecommissie

Promotor:!! ! ! ! prof. dr. D. W. Hommes

Co-promotores:! ! ! dr. H. Roelofs

! ! ! ! ! ! ! prof. dr. G.R. van den Brink (Academisch Medisch Centrum, Amsterdam)

Overige leden:! ! ! prof. dr. L. Egan (University of Galway, Galway, Ireland)

! ! ! ! ! ! ! prof. dr. W.E. Fibbe

! ! ! ! ! ! ! prof. dr. F. Koning

! ! ! ! ! ! ! prof. dr. C.L. Mummery

! ! ! ! ! ! ! prof. dr. A.J. Rabelink

! ! ! ! ! ! ! dr. P.C.F. Stokkers (Sint Lucas Andreas Ziekenhuis, Amsterdam)

(6)
(7)
(8)

TABLE OF CONTENTS

Chapter 1!! Introduction

! ! ! ! Journal of Crohn's and Colitis 2008 Jun;2(2):99-106 and Inflammatory Bowel Disease Monitor 2010;11(2):57–64.

Chapter 2!! Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn`s disease

! ! ! ! Journal of Crohn’s and Colitis 2011 Dec;5(6):543-9.

Chapter 3!! Autologous bone marrow derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study

! ! ! ! Gut 2010;59:1662-1669.

Chapter 4!! Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease

! ! ! ! Cytotherapy 2011 Oct;13(9):1066-73.

Chapter 5!! Pretreatment with interferon-gamma enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis

! ! ! ! Stem Cells 2011 Oct;29(10):1549-58.

Chapter 6 ! Summary, discussion, and future perspectives

! ! ! ! Samenvatting, discussie en toekomstperspectieven Chapter 7!! List of publications

! ! ! ! Curriculum Vitae

! ! ! ! Acknowledgements!

! ! ! ! Abbreviations

9

25

37

53

65

85 89 96 99 100 103

Referenties

GERELATEERDE DOCUMENTEN

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Our data imply that MSCs isolated from Crohn’s disease patients have similar characteristics compared to MSCs from healthy donors and that administration of

Daarnaast laat deze studie zien dat het toedienen van autologe MSCs veilig en haalbaar is in de behandeling van de ziekte Crohn; er zijn geen ernstige

After completing her gastroenterology rotation and graduating medical school in 2007, Marjolijn received a grant from the Maag Lever Darm Stichting (MLDS) to initiate and

Autologous MSCs can be safely administered intravenous to Crohn’s disease patients (this thesis)4. MSCs from Crohn’s disease patients are similar to MSCs of healthy volunteers (this

Moreover, the thermal stabilization maintains the structural integrity of lignin without obvious degradation, as demonstrated by Fourier transform infrared (FTIR) spec-